🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/06/2005 | 30,11 | 30,39 | 30,02 | 30,32 | +0,73% | 1,24% | 5.293.029 |
| 13/06/2005 | 29,60 | 30,22 | 29,59 | 30,11 | +0,51% | 2,13% | 6.473.286 |
| 10/06/2005 | 29,87 | 30,05 | 29,66 | 29,95 | +0,13% | 1,31% | 7.843.442 |
| 09/06/2005 | 30,06 | 30,18 | 29,82 | 29,91 | -0,89% | 1,21% | 7.796.701 |
| 08/06/2005 | 30,70 | 30,70 | 30,13 | 30,18 | -1,40% | 1,83% | 8.048.011 |
| 07/06/2005 | 30,57 | 30,91 | 30,51 | 30,61 | +0,16% | 1,31% | 5.595.796 |
| 06/06/2005 | 30,59 | 30,64 | 30,45 | 30,56 | -0,19% | 0,62% | 4.753.728 |
| 03/06/2005 | 30,75 | 30,75 | 30,44 | 30,62 | -0,43% | 1,02% | 5.952.745 |
| 02/06/2005 | 30,70 | 30,77 | 30,53 | 30,75 | +0,12% | 0,78% | 5.426.649 |
| 01/06/2005 | 30,73 | 30,92 | 30,45 | 30,72 | -0,77% | 1,52% | 8.205.840 |
| 31/05/2005 | 30,96 | 31,06 | 30,80 | 30,95 | -0,03% | 0,83% | 14.101.574 |
| 27/05/2005 | 30,92 | 31,09 | 30,83 | 30,96 | +0,31% | 0,83% | 5.349.097 |
| 26/05/2005 | 31,19 | 31,19 | 30,74 | 30,87 | -0,58% | 1,44% | 8.788.947 |
| 25/05/2005 | 31,25 | 31,37 | 30,97 | 31,05 | -0,61% | 1,28% | 7.042.665 |
| 24/05/2005 | 31,36 | 31,73 | 31,24 | 31,24 | +0,34% | 1,55% | 8.265.262 |
| 23/05/2005 | 31,01 | 31,45 | 30,99 | 31,14 | +0,03% | 1,48% | 6.123.254 |
| 20/05/2005 | 31,38 | 31,44 | 31,13 | 31,13 | -0,52% | 1,00% | 9.450.864 |
| 19/05/2005 | 31,25 | 31,36 | 31,06 | 31,29 | -0,49% | 0,95% | 6.531.450 |
| 18/05/2005 | 31,71 | 31,72 | 31,15 | 31,44 | -0,18% | 1,81% | 11.385.053 |
| 17/05/2005 | 31,49 | 31,56 | 31,10 | 31,50 | -1,32% | 1,48% | 12.939.866 |
| 16/05/2005 | 32,03 | 32,05 | 31,77 | 31,92 | -0,03% | 0,86% | 6.454.946 |
| 13/05/2005 | 32,20 | 32,20 | 31,78 | 31,93 | -0,53% | 1,30% | 7.898.881 |
| 12/05/2005 | 32,01 | 32,25 | 31,87 | 32,10 | +0,42% | 1,19% | 5.908.729 |
| 11/05/2005 | 32,33 | 32,39 | 31,87 | 31,97 | -1,12% | 1,59% | 6.829.606 |
| 10/05/2005 | 32,54 | 32,57 | 32,11 | 32,33 | -0,94% | 1,41% | 6.538.262 |
| 09/05/2005 | 32,46 | 32,67 | 32,24 | 32,63 | +0,12% | 1,32% | 7.356.541 |
| 06/05/2005 | 33,25 | 33,59 | 32,45 | 32,60 | -1,70% | 3,41% | 7.602.821 |
| 05/05/2005 | 33,33 | 33,44 | 32,78 | 33,16 | -0,52% | 2,00% | 8.509.655 |
| 04/05/2005 | 32,76 | 33,35 | 32,74 | 33,33 | +1,48% | 1,86% | 7.309.066 |
| 03/05/2005 | 32,59 | 32,85 | 32,44 | 32,84 | +1,24% | 1,26% | 7.513.636 |